BPMC - Blueprint Medicines' (BPMC) CEO Jeff Albers on Q4 2021 Results - Earnings Call Transcript
Blueprint Medicines Corporation (BPMC) Q4 2021 Earnings Conference Call February 16, 2022 8:30 AM ET Company Participants Kristin Hodous – Senior Manager-Investor Relations Jeff Albers – Chief Executive Officer Kate Haviland – Chief Operating Officer Christy Rossi – Chief Commercial Officer Becker Hewes – Chief Medical Officer Mike Landsittel – Chief Financial Officer Fouad Namouni – President-Research & Development Conference Call Participants Marc Frahm – Cowen Dane Leone – Raymond James Brad Canino – Stifel Reni Benjamin – JMP Securities Mike Ulz – Morgan Stanley Eun Yang – Jefferies Joel Beatty – Baird Michael Schmidt – Guggenheim Peter Lawson – Barclays Presentation Operator Good morning. My name is Lydia and I will be your conference operator today. At this time, I'd like to welcome everyone to the Blueprint Medicines’ Fourth Quarter and Full Year 2021 Financial Results Conference Call. [Operator Instructions] Thank you. Kristin Hodous you may begin your conference.
For further details see:
Blueprint Medicines' (BPMC) CEO Jeff Albers on Q4 2021 Results - Earnings Call Transcript